Reteplase

Formulation (FDF) · 18mg/10ml

Formulation (FDF)Confidentiality：Public

INN / Generic Name: Reteplase
Dosage Form: —
Strength: 18mg/10ml
Therapy Area: Cardiovascular
Indication: Thrombocytopenia
Current Status: Official FDF licensing catalog (UB007)
GMP Certification: CN - NMPA
CEP: No
DMF Type: —
Stability Data: —
BE Required: Not required / waivable
Registration Pathway: Registered (market rights transferable / DCP·NP per market)
MOQ: On request
Lead Time: On request
Price Range: On request

HS Code

3004.903 customs bills on file

Registrable Markets

China

Process / Sequence / Exact Price